Glycosylation of human proteinase-activated receptor-2 (hPAR2) role in cell surface expression and signalling

被引:103
作者
Compton, SJ
Sandhu, S
Wijesuriya, SJ
Hollenberg, MD
机构
[1] Univ Calgary, Mucosal Inflammat Res Grp, Dept Pharmacol & Therapeut, Fac Med, Calgary, AB T2N 4N1, Canada
[2] Univ Calgary, Diabet & Endocrine Res Grp, Fac Med, Calgary, AB T2N 4N1, Canada
关键词
inflammation; protease; sialylation; tryptase;
D O I
10.1042/BJ20020706
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have analysed the role of N-linked glycosylation in regulating human proteinase-activated receptor-2 (hPAR(2)) expression and function. Epitope-tagged wild-type hPAR(2) (wt-hPAR(2)) or hPAR 2 that lacked glycosylation sequons (following site-directed mutagenesis) in either the N-terminus [hPAR(2)N30A (Asn(30) --> Ala)], extracellular loop 2 [ECL2; hPAR(2)N222Q (Asn(222) --> Gln) or hPAR(2)N222A (Asn(222) --> Ala)] or both (hPAR(2)N30A,N222A or hPAR(2)N30A,N222Q) were expressed in the Chinese-hamster ovary (CHO) fibroblast cell line, Pro5. Western blot analysis of wt-hPAR(2) showed mature wt-hPAR(2) to have a molecular mass of 55-100 kDa, and 33-48 kDa following N-glycosidase F deglycosylation. FACS analysis and immunocytochemistry of the wt-hPAR(2) and PAR(2) mutant cell lines revealed that removal of both glycosylation sequons decreases (50 % of wt-hPAR(2)) cell surface expression. Western blot analysis indicated that both N-linked sites are glycosylated. In functional studies, hPAR(2)N30A displayed a selective and significant increase in sensitivity towards tryptase. Interestingly, hPAR(2)N222A displayed a loss in sensitivity towards all PAR(2) agonists tested. However, further analysis revealed receptor sensitivity to alanine mutations in this domain, as the more conservative substitution hPAR(2)N222Q displayed no change in response to PAR 2 agonists. hPAR(2)N30A,N222Q displayed increased sensitivity towards tryptase, but a loss in sensitivity towards trypsin and the synthetic peptide SLIGRL-NH2, although this loss in sensitivity towards trypsin and SLIGRL-NH2, was secondary to changes in cell-surface expression. Finally, expression of sialic-acid-deficient wt-hPAR(2) in the CHO Lec2 glycosylation-deficient mutant cell line, showed a 40 kDa loss in molecular mass, in addition to a marked and selective increase in sensitivity towards tryptase. We conclude that hPAR 2 N-linked glycosylation and sialylation regulates receptor expression and/ or signalling.
引用
收藏
页码:495 / 505
页数:11
相关论文
共 38 条
  • [1] Proteinase activated receptor 2: role of extracellular loop 2 for ligand-mediated activation
    Al-Ani, B
    Saifeddine, M
    Kawabata, A
    Hollenberg, MD
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1999, 128 (05) : 1105 - 1113
  • [2] Glycosylation and rheumatic disease
    Axford, JS
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1999, 1455 (2-3): : 219 - 229
  • [3] Extracellular mutations of protease-activated receptor-1 result in differential activation by thrombin and thrombin receptor agonist peptide
    Blackhart, BD
    Ruslim-Litrus, L
    Lu, CC
    Alves, VL
    Teng, W
    Scarborough, RM
    Reynolds, EE
    Oksenberg, D
    [J]. MOLECULAR PHARMACOLOGY, 2000, 58 (06) : 1178 - 1187
  • [4] Bohm SK, 1996, J BIOL CHEM, V271, P22003
  • [5] Bohm SK, 1996, BIOCHEM J, V314, P1009
  • [6] Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa
    Camerer, E
    Huang, W
    Coughlin, SR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (10) : 5255 - 5260
  • [7] A polymorphic protease-activated receptor 2 (PAR2) displaying reduced sensitivity to trypsin and differential responses to PAR agonists
    Compton, SJ
    Cairns, JA
    Palmer, KJ
    Al-Ani, B
    Hollenberg, MD
    Walls, AF
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (50) : 39207 - 39212
  • [8] Glycosylation and the activation of proteinase-activated receptor 2 (PAR2) by human mast cell tryptase
    Compton, SJ
    Renaux, B
    Wijesuriya, SJ
    Hollenberg, MD
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2001, 134 (04) : 705 - 718
  • [9] Compton SJ, 1998, J IMMUNOL, V161, P1939
  • [10] Proteinase-activated receptors:: novel mechanisms of signaling by serine proteases
    Déry, O
    Corvera, CU
    Steinhoff, M
    Bunnett, NW
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 1998, 274 (06): : C1429 - C1452